Journey Medical (DERM) Non-Current Assets (2020 - 2026)

Journey Medical (DERM) has reported Non-Current Assets for 7 consecutive years, with $25.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non-Current Assets fell 14.44% year-over-year to $25.6 million; the trailing twelve-month figure through Jun 2026 stood at $108.7 million (down 1.94% YoY), and the FY2025 full-year result was $27.7 million, down 13.55% from the prior year.
• Non-Current Assets eased to $25.6 million in Q2 2026 per DERM's latest filing, from $26.6 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $35.1 million in Q1 2023 and bottomed at $17.9 million in Q3 2024.
• Historically, Non-Current Assets has averaged $26.3 million across 5 years, with a median of $27.6 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Non-Current Assets jumped 114.85% in 2022, then sank 44.33% in 2024.
• Over 5 years, Non-Current Assets stood at $27.5 million in 2022, then dropped by 25.79% to $20.4 million in 2023, then soared by 57.21% to $32.1 million in 2024, then slipped by 13.55% to $27.7 million in 2025, then decreased by 7.72% to $25.6 million in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $25.6 million, $26.6 million, and $27.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.